| S9697 |
Semaglutide
|
Semaglutide is an oral agonist of glucagon-like peptide-1 receptor (GLP1R), used for treating type 2 diabetes and obesity by enhancing insulin secretion, reducing glucagon levels, and promoting weight loss. It is available in subcutaneous and oral formulations.
|
-
Cancer Cell, 2025, 43(4):776-796.e14
-
Nat Commun, 2024, 15(1):7991
|
|
| S9852 |
Orforglipron (LY3502970)
|
Orforglipron (LY3502970) is a non-peptidal agonist of glucagon-like peptide 1 (GLP-1) receptor. It can be used efficiently in glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM), obesity or both.
|
|
|
| E7333 |
Semaglutide Sodium
|
Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM).
|
-
Cancers (Basel), 2025, 17(4)598
|
|
| P1247 |
Exendin-4
|
Exendin-4 (Exenatide) is a 39-amino acid peptide and a long-acting potent agonist of glucagon-like peptide-1(GLP-1) receptor with an IC50 of 3.22 nM. It is used in research and as a potential long-term treatment for type 2 diabetes mellitus.
|
-
Mater Today Bio, 2025, 33:102009
|
|
| E1173 |
V-0219
|
V-0219 is an orally active, positive allosteric modulator (PAM) of the glucagon-like peptide-1 receptor (GLP-1R), can be used for obesity-associated diabetes research.
|
|
|
| S3734 |
Albiglutide Fragment
|
Albiglutide fragment is one copy of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36).
|
|
|
| S0555 |
Adomeglivant
|
Adomeglivant (LY2409021) is a potent and selective antagonist of glucagon receptor that is used as a chronic treatment for type 2 diabetes.
|
|
|
| S8517 |
Lixisenatide
|
Lixisenatide (Lyxumia, Adlyxin, ZP10A peptide, AVE0010) is a once-daily short-acting glucagon-like peptide-1 (GLP-1) receptor agonist (GLP-1RA) with an IC50 of 1.4 nM for the human GLP-1 receptor in receptor binding studies.
|
|
|
| S9935 |
Teduglutide (ALX-0600)
|
Teduglutide (ALX-0600, Gattex, Revestive, TAK 633) is an analogue of human glucagon-like peptide-2 (GLP-2) and binds to the GLP-2 receptors. Teduglutide prolongs the intestinotrophic properties of GLP-2 in animal models.
|
|
|
| E4779 |
DMB
|
DMB (GLP-1R agonist 2, Compound 2) is an agonist of the GLP-1 receptor (GLP-1R) with a Ki of 13.25 µM. It activates GLP-1R by forming hydrogen bonds with the Tyr42, Cys71, and Ser84 residues. This compound attenuates transient focal cerebral ischemia injury and inhibits neuronal apoptosis induced by MCAO.
|
|
|